Endomagnetics reveals new brand identity Endomag

NewsGuard 100/100 Score

Endomagnetics is revealing a new brand identity that accurately reflects its position as a global leader in the development of devices for cancer care based on the application of advanced magnetic technologies. 

The identity for newly named Endomag has been built around the business’ uncompromising vision of ‘access to cancer care for all’. Since entering the market in November 2012, the company has developed rapidly and now operates a distribution network across Europe, the Middle East, Africa and Australia, with plans for US launch in 2016.

Its success to date has been in the field of diagnostics, but the use of magnetics as a minimally invasive treatment has huge potential in therapeutics. Following its acquisition of the ACT portfolio earlier this year, Endomag is now developing its magnetics platform to cover both diagnostic and therapeutic applications for cancer care.

The new brand has been carefully developed to not only reflect the expanded business today, but to also appeal to its audience of patients, clinicians and healthcare providers in the simplest way possible. While the trading name remains the same, the company will be referred to as ‘Endomag’ which translates more easily across languages in current and future markets. The new logo uses colours that reflect the business’ focus on both clinical excellence and human experience. The two contrasting elements of the circle represent a magnet, with the two forces working together.

Eric Mayes, CEO at Endomag, said:

We’re dedicated to solving challenges in cancer care, and bringing the benefits to as many people as possible. Magnetism is the only non-invasive energy that can safely access the entire body, and directing that energy using our magnetic tracer gives our portfolio huge scope for a range of diagnostic and therapeutic applications. Following our recent round of funding, we have some very exciting plans for 2015 and beyond. We’re looking forward to this next chapter in our business as Endomag and all that the new brand represents.

Source: www.endomag.com

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Firefighters at increased risk of prostate cancer due to chemical exposures, study reveals